{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:42:22Z","timestamp":1791553342470,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity is common comorbidity in patients with schizophrenia. Previous studies have reported that homocysteine (Hcy) is increased in schizophrenia. However, no study has reported the association between BMI and Hcy levels in schizophrenia. This cross-sectional naturalistic study aimed to evaluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic schizophrenia. Clinical and anthropometric data as well as plasma Hcy level and glycolipid parameters were collected. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Our results showed that compared with the low BMI group, the high BMI group had a higher PANSS general psychopathology subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cholesterol (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Hcy levels were negatively associated with BMI in patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Hcy level, the PANSS general psychopathology subscale, total cholesterol and education (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) were the influencing factors of high BMI. Our study suggest that Hcy level may be associated with BMI in patients with schizophrenia. Moreover, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels.<\/jats:p>","DOI":"10.1038\/s41598-020-72934-3","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T10:05:26Z","timestamp":1601460326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia"],"prefix":"10.1038","volume":"10","author":[{"given":"Yuanyuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"72934_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen, T. M., Nordentoft, M. & Mortensen, P. B. Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 10, 425\u2013448 (2014).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"72934_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.psychres.2016.12.041","volume":"251","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. Psychiatry Res. 251, 131\u2013136 (2017).","journal-title":"Psychiatry Res."},{"key":"72934_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41398-019-0502-x","volume":"9","author":"T Pillinger","year":"2019","unstructured":"Pillinger, T. et al. Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study. Transl. Psychiatry 9, 163 (2019).","journal-title":"Transl. Psychiatry"},{"key":"72934_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.schres.2019.10.017","volume":"215","author":"Y Tian","year":"2019","unstructured":"Tian, Y. et al. Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits. Schizophr. Res. 215, 270 (2019).","journal-title":"Schizophr. Res."},{"key":"72934_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker, E. R., McGee, R. E. & Druss, B. G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72, 334\u2013341 (2015).","journal-title":"JAMA Psychiatry"},{"key":"72934_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clnesp.2017.09.013","volume":"23","author":"MK Barker","year":"2018","unstructured":"Barker, M. K. et al. Diet and cardiometabolic side effects in children treated with second-generation antipsychotics. Clin. Nutr. ESPEN 23, 205\u2013211 (2018).","journal-title":"Clin. Nutr. ESPEN"},{"key":"72934_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","volume":"17","author":"CU Correll","year":"2011","unstructured":"Correll, C. U., Lencz, T. & Malhotra, A. K. Antipsychotic drugs and obesity. Trends Mol. Med. 17, 97\u2013107 (2011).","journal-title":"Trends Mol. Med."},{"key":"72934_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort, D. et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14, 339\u2013347 (2015).","journal-title":"World Psychiatry"},{"key":"72934_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.psyneuen.2015.09.005","volume":"62","author":"XY Zhang","year":"2015","unstructured":"Zhang, X. Y. et al. Glucose disturbances in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology. Psychoneuroendocrinology 62, 376\u2013380 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"72934_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert, M., Detraux, J., van Winkel, R., Yu, W. & Correll, C. U. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat. Rev. Endocrinol. 8, 114\u2013126 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"72934_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jnr.10416","volume":"70","author":"PI Ho","year":"2002","unstructured":"Ho, P. I., Ortiz, D., Rogers, E. & Shea, T. B. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70, 694\u2013702 (2002).","journal-title":"J. Neurosci. Res."},{"key":"72934_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ijms19030891","volume":"19","author":"N Shirafuji","year":"2018","unstructured":"Shirafuji, N. et al. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization. Int. J. Mol. Sci. 19, 891 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"72934_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","volume":"8","author":"AA Moustafa","year":"2014","unstructured":"Moustafa, A. A., Hewedi, D. H., Eissa, A. M., Frydecka, D. & Misiak, B. Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front Behav. Neurosci. 8, 343 (2014).","journal-title":"Front Behav. Neurosci."},{"key":"72934_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.schres.2014.07.033","volume":"159","author":"X Song","year":"2014","unstructured":"Song, X. et al. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug na\u00efve, first episode schizophrenia. Schizophr. Res. 159, 51\u201355 (2014).","journal-title":"Schizophr. Res."},{"key":"72934_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/schbul\/sbr034","volume":"37","author":"PJ Uhlhaas","year":"2011","unstructured":"Uhlhaas, P. J. & Singer, W. The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis. Schizophr. Bull. 37, 514\u2013523 (2011).","journal-title":"Schizophr. Bull."},{"key":"72934_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.psychres.2017.08.063","volume":"259","author":"SJ Zhou","year":"2018","unstructured":"Zhou, S. J. et al. Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population. Psychiatry. Res. 259, 364\u2013369 (2018).","journal-title":"Psychiatry. Res."},{"key":"72934_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s12035-017-0493-7","volume":"55","author":"L Canever","year":"2018","unstructured":"Canever, L. et al. The evaluation of folic acid-deficient or folic acid-supplemented diet in the gestational phase of female rats and in their adult offspring subjected to an animal model of schizophrenia. Mol. Neurobiol. 55, 2301\u20132319 (2018).","journal-title":"Mol. Neurobiol."},{"key":"72934_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","volume":"32","author":"ND Petronijevi\u0107","year":"2008","unstructured":"Petronijevi\u0107, N. D. et al. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1921\u20131926 (2008).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"72934_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.mp.4001746","volume":"11","author":"JW Muntjewerff","year":"2006","unstructured":"Muntjewerff, J. W., Kahn, R. S., Blom, H. J. & den Heijer, M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11, 143\u2013149 (2006).","journal-title":"Mol. Psychiatry"},{"key":"72934_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00406-012-0302-2","volume":"262","author":"R Ayesa-Arriola","year":"2012","unstructured":"Ayesa-Arriola, R. et al. Homocysteine and cognition in first-episode psychosis patients. Eur. Arch. Psychiatry Clin. Neurosci. 262, 557\u2013564 (2012).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"72934_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biopsych.2005.10.009","volume":"60","author":"J Levine","year":"2006","unstructured":"Levine, J. et al. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol. Psychiatry 60, 265\u2013269 (2006).","journal-title":"Biol. Psychiatry"},{"key":"72934_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijerph14040376","volume":"14","author":"Y Chang","year":"2017","unstructured":"Chang, Y. et al. The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: a cross-sectional study from Northeast China. Int. J. Environ. Res. Public Health 14, 376 (2017).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"72934_CR23","first-page":"1756","volume":"17","author":"W Liu","year":"2019","unstructured":"Liu, W., Wang, T., Sun, P. & Zhou, Y. Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD. Exp. Ther. Med. 17, 1756\u20131760 (2019).","journal-title":"Exp. Ther. Med."},{"key":"72934_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00394-010-0165-0","volume":"50","author":"M Nakazato","year":"2011","unstructured":"Nakazato, M. et al. Relation of body mass index to blood folate and total homocysteine concentrations in Japanese adults. Eur. J. Nutr. 50, 581\u2013585 (2011).","journal-title":"Eur. J. Nutr."},{"key":"72934_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2147\/DMSO.S205379","volume":"12","author":"L Fu","year":"2019","unstructured":"Fu, L., Li, Y. N., Luo, D., Deng, S. & Hu, Y. Q. Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 38,317 individuals implementing Mendelian randomization. Diabetes Metab. Syndr. Obes. 12, 1201\u20131212 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"72934_CR26","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/nu11071614","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Central but not general obesity is positively associated with the risk of hyperhomocysteinemia in middle-aged women. Nutrients 11, 1614 (2019).","journal-title":"Nutrients"},{"key":"72934_CR27","unstructured":"Ji, C. Y., Chen, T. J. & Working Group on Obesity in China (WGOC). Empirical changes in the prevalence of overweight and obesity among Chinese students from 1985 to 2010 and corresponding preventive strategies. Biomed. Environ. Scis 26, 1\u201312 (2013)."},{"key":"72934_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/ajcn\/88.3.738","volume":"88","author":"AK Elshorbagy","year":"2008","unstructured":"Elshorbagy, A. K. et al. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism. Am. J. Clin. Nutr. 88, 738\u2013746 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"72934_CR29","doi-asserted-by":"crossref","unstructured":"Ganji, V., Kafai, M. R. & Third National Health and Nutrition Examination Survey. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988\u20131994. Am. J. Clin. Nutr. 77, 826\u2013833 (2003).","DOI":"10.1093\/ajcn\/77.4.826"},{"key":"72934_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","volume":"33","author":"E Elci","year":"2017","unstructured":"Elci, E., Kaya, C., Cim, N., Yildizhan, R. & Elci, G. G. Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol. Endocrinol. 33, 43\u201347 (2017).","journal-title":"Gynecol. Endocrinol."},{"key":"72934_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-08-0056","volume":"159","author":"SJ Lewis","year":"2008","unstructured":"Lewis, S. J. et al. The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts. Eur. J. Endocrinol. 159, 35\u201340 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"72934_CR32","doi-asserted-by":"publisher","first-page":"1826780","DOI":"10.1155\/2019\/1826780","volume":"2019","author":"A Lima","year":"2019","unstructured":"Lima, A., Ferin, R., Bourbon, M., Baptista, J. & Pav\u00e3o, M. L. Hypercysteinemia, a potential risk factor for central obesity and related disorders in Azores, Portugal. J. Nutr. Metab. 2019, 1826780 (2019).","journal-title":"J. Nutr. Metab."},{"key":"72934_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/09637486.2018.1547688","volume":"70","author":"A Foscolou","year":"2019","unstructured":"Foscolou, A. et al. The association between homocysteine levels, Mediterranean diet and cardiovascular disease: a case-control study. Int. J. Food. Sci. Nutr. 70, 603\u2013611 (2019).","journal-title":"Int. J. Food. Sci. Nutr."},{"key":"72934_CR34","doi-asserted-by":"publisher","first-page":"e12626","DOI":"10.1097\/MD.0000000000012626","volume":"97","author":"J Liu","year":"2018","unstructured":"Liu, J., Quan, J., Li, Y., Wu, Y. & Yang, L. Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: A STROBE-compliant observational study. Medicine (Baltimore) 97, e12626 (2018).","journal-title":"Medicine (Baltimore)"},{"key":"72934_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2017.04.025","volume":"650","author":"N Fan","year":"2017","unstructured":"Fan, N. et al. Effect of risperidone on serum homocysteine levels in first-episode, drug-na\u00efve patients with schizophrenia. Neurosci. Lett. 650, 168\u2013173 (2017).","journal-title":"Neurosci. Lett."},{"key":"72934_CR36","first-page":"e5","volume":"17","author":"LS Cheng","year":"2010","unstructured":"Cheng, L. S., Prasad, A. N. & Rieder, M. J. Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents. Can. J. Clin. Pharmacol. 17, e5-46 (2010).","journal-title":"Can. J. Clin. Pharmacol."},{"key":"72934_CR37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3109\/0886022X.2010.504911","volume":"32","author":"Y Bhalodia","year":"2010","unstructured":"Bhalodia, Y., Sheth, N., Vaghasiya, J. & Jivani, N. Role of fenofibrate alone and in combination with telmisartan on renal ischemia\/reperfusion injury. Ren Fail. 32, 1088\u20131094 (2010).","journal-title":"Ren Fail."},{"key":"72934_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3346\/jkms.2013.28.7.1015","volume":"28","author":"SB Park","year":"2013","unstructured":"Park, S. B. & Georgiades, A. Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea. J. Korean Med. Sci. 28, 1015\u20131020 (2013).","journal-title":"J. Korean Med. Sci."},{"key":"72934_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jn\/137.2.311","volume":"137","author":"KT Williams","year":"2007","unstructured":"Williams, K. T. & Schalinske, K. L. New insights into the regulation of methyl group and homocysteine metabolism. J. Nutr. 137, 311\u2013314 (2007).","journal-title":"J. Nutr."},{"key":"72934_CR40","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1053\/meta.2001.25646","volume":"50","author":"S Gallistl","year":"2001","unstructured":"Gallistl, S., Sudi, K. M., Erwa, W., Aigner, R. & Borkenstein, M. Determinants of homocysteine during weight reduction in obese children and adolescents. Metabolism 50, 1220\u20131223 (2001).","journal-title":"Metabolism"},{"key":"72934_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12944-017-0441-6","volume":"16","author":"M Momin","year":"2017","unstructured":"Momin, M. et al. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids Health Dis. 16, 54 (2017).","journal-title":"Lipids Health Dis."},{"key":"72934_CR42","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1038\/s41598-019-41713-0","volume":"9","author":"JM Lee","year":"2019","unstructured":"Lee, J. M. et al. BRD7 deficiency leads to the development of obesity and hyperglycemia. Sci. Rep. 9, 5327 (2019).","journal-title":"Sci. Rep."},{"key":"72934_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jnutbio.2019.05.012","volume":"71","author":"S Kannan","year":"2019","unstructured":"Kannan, S., Srinivasan, D., Raghupathy, P. B. & Bhaskaran, R. S. Association between duration of obesity and severity of ovarian dysfunction in rat-cafeteria diet approach. J. Nutr. Biochem. 71, 132\u2013143 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"72934_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.schres.2011.01.022","volume":"128","author":"E Hermes","year":"2011","unstructured":"Hermes, E. et al. The association between weight change and symptom reduction in the CATIE schizophrenia trial. Schizophr. Res. 128, 166\u2013170 (2011).","journal-title":"Schizophr. Res."},{"key":"72934_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2013.01.010","volume":"145","author":"CA Janney","year":"2013","unstructured":"Janney, C. A. et al. Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study). Schizophr. Res. 145, 63\u201368 (2013).","journal-title":"Schizophr. Res."},{"key":"72934_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/0269881105058978","volume":"19","author":"H Ascher-Svanum","year":"2005","unstructured":"Ascher-Svanum, H., Stensland, M. D., Kinon, B. J. & Tollefson, G. D. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J. Psychopharmacol. 19, 110\u2013117 (2005).","journal-title":"J. Psychopharmacol."},{"key":"72934_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.psychres.2014.12.035","volume":"225","author":"L Hui","year":"2015","unstructured":"Hui, L. et al. Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: gender difference. Psychiatry Res. 225, 741\u2013742 (2015).","journal-title":"Psychiatry Res."},{"key":"72934_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/cap.2012.0099","volume":"23","author":"DE Kemp","year":"2013","unstructured":"Kemp, D. E. et al. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia. J. Child. Adolesc. Psychopharmacol. 23, 522\u2013530 (2013).","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"72934_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4306\/pi.2015.12.2.242","volume":"12","author":"SH Kang","year":"2015","unstructured":"Kang, S. H. & Lee, J. I. Metabolic disturbances independent of body mass in patients with schizophrenia taking atypical antipsychotics. Psychiatry Investig. 12, 242\u2013248 (2015).","journal-title":"Psychiatry Investig."},{"key":"72934_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0920-9964(01)00326-7","volume":"59","author":"HY Meltzer","year":"2003","unstructured":"Meltzer, H. Y., Perry, E. & Jayathilake, K. Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr. Res. 59, 19\u201327 (2003).","journal-title":"Schizophr. Res."},{"key":"72934_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/sms.13371","volume":"29","author":"MF Brobakken","year":"2019","unstructured":"Brobakken, M. F. et al. A comprehensive cardiovascular disease risk profile in patients with schizophrenia. Scand. J. Med. Sci. Sports 29, 575\u2013585 (2019).","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"72934_CR52","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung, U. J. & Choi, M. S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 15, 6184\u20136223 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"72934_CR53","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1038\/s41598-017-05785-0","volume":"7","author":"CA Pickens","year":"2017","unstructured":"Pickens, C. A., Vazquez, A. I., Jones, A. D. & Fenton, J. I. Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach. Sci. Rep. 7, 6335 (2017).","journal-title":"Sci. Rep."},{"key":"72934_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41398-018-0303-7","volume":"8","author":"H An","year":"2018","unstructured":"An, H. et al. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients. Transl. Psychiatry 8, 258 (2018).","journal-title":"Transl. Psychiatry"},{"key":"72934_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/JCP.0000000000000058","volume":"34","author":"M Subramaniam","year":"2014","unstructured":"Subramaniam, M. et al. Body mass index, obesity, and psychopathology in patients with schizophrenia. J. Clin. Psychopharmacol. 34, 40\u201346 (2014).","journal-title":"J. Clin. Psychopharmacol."},{"key":"72934_CR56","first-page":"217","volume":"9","author":"G Veghari","year":"2013","unstructured":"Veghari, G. et al. The correlation between educational levels and central obesity in the north of Iran: an epidemiologic study. ARYA Atheroscler. 9, 217\u2013222 (2013).","journal-title":"ARYA Atheroscler."},{"key":"72934_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpsychires.2019.05.004","volume":"115","author":"M Garriga","year":"2019","unstructured":"Garriga, M. et al. Antipsychotic-induced weight gain and birth weight in psychosis: a fetal programming model. J. Psychiatr. Res. 115, 29\u201335 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"72934_CR58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn, M. et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394, 939\u2013951 (2019).","journal-title":"Lancet"},{"key":"72934_CR59","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00213-018-5107-1","volume":"236","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia. Psychopharmacology 236, 753\u2013762 (2019).","journal-title":"Psychopharmacology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72934-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:13:11Z","timestamp":1670357591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72934-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16119"}}